{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:08:18Z","timestamp":1777669698506,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004635","name":"Fru Berta Kamprads Stiftelse","doi-asserted-by":"publisher","award":["FBKS-2018-R22 (167)"],"award-info":[{"award-number":["FBKS-2018-R22 (167)"]}],"id":[{"id":"10.13039\/501100004635","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Governmental Funding of Clinical Research within the National Health Service Sweden","award":["ALF; 2018-Project 0211 AR"],"award-info":[{"award-number":["ALF; 2018-Project 0211 AR"]}]},{"name":"M\u00e4rit and Hans Rausing Initiative Against Breast Cancer","award":["Personal donation"],"award-info":[{"award-number":["Personal donation"]}]},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To study the incidence and subtype of breast cancer in relation to incident and prevalent statin use in a contemporary Swedish prospective cohort, The Karolinska Mammography Project for Risk Prediction of Breast Cancer, KARMA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 35,315 postmenopausal women attending mammography and included in the KARMA cohort (Jan 2011\u2013March 2013) with data on statin use and potential confounders were studied. During eight years of follow-up, 785 incident invasive breast cancer cases were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 16% of women were prevalent statin users (prior to study inclusion) and 9% were incident statin users (following study inclusion). In multivariable Cox regression analyses, there was no significant association between incident or prevalent statin use and risk of incident breast cancer (HR\n                      <jats:sub>adj<\/jats:sub>\n                      1.24, 95% CI 0.89\u20131.72, and HR\n                      <jats:sub>adj<\/jats:sub>\n                      0.90, 95% CI 0.73\u20131.11, respectively). Similarly, no significant association was found for incident or prevalent statin use and subtype-specific risk of breast cancer.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This prospective population-based study performed in a modern screening population with a substantial number of statin users, concurs with previous publications showing no evidence of an association between statin use and risk of postmenopausal breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10552-026-02156-x","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T13:44:41Z","timestamp":1775223881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Statins and postmenopausal breast cancer risk; results from the KARMA cohort"],"prefix":"10.1007","volume":"37","author":[{"given":"Marie","family":"Klintman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann H.","family":"Rosendahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin R.","family":"Johannesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deirdre","family":"Cronin-Fenton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikael","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamila","family":"Czene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Signe","family":"Borgquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"issue":"19","key":"2156_CR1","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.2015.15629","volume":"316","author":"R Chou","year":"2016","unstructured":"Chou R et al (2016) Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA 316(19):2008\u20132024","journal-title":"JAMA"},{"key":"2156_CR2","doi-asserted-by":"crossref","unstructured":"Sacks, F.M., et al., (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 335(14):1001\u20131009.","DOI":"10.1056\/NEJM199610033351401"},{"issue":"1","key":"2156_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1001\/jama.1996.03530250059028","volume":"275","author":"TB Newman","year":"1996","unstructured":"Newman TB, Hulley SB (1996) Carcinogenicity of lipid-lowering drugs. JAMA 275(1):55\u201360","journal-title":"JAMA"},{"issue":"17","key":"2156_CR4","doi-asserted-by":"publisher","first-page":"8707","DOI":"10.1158\/0008-5472.CAN-05-4061","volume":"66","author":"MJ Campbell","year":"2006","unstructured":"Campbell MJ et al (2006) Breast cancer growth prevention by statins. Cancer Res 66(17):8707\u20138714","journal-title":"Cancer Res"},{"issue":"10","key":"2156_CR5","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.1016\/S1470-2045(14)70119-6","volume":"15","author":"TP Ahern","year":"2014","unstructured":"Ahern TP et al (2014) Statins and breast cancer prognosis: evidence and opportunities. Lancet Oncol 15(10):e461\u2013e468","journal-title":"Lancet Oncol"},{"issue":"1","key":"2156_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","volume":"161","author":"JL Goldstein","year":"2015","unstructured":"Goldstein JL, Brown MS (2015) A century of cholesterol and coronaries: from plaques to genes to statins. Cell 161(1):161\u2013172","journal-title":"Cell"},{"issue":"1","key":"2156_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13058-018-1066-z","volume":"20","author":"CH Beckwitt","year":"2018","unstructured":"Beckwitt CH et al (2018) Statin drugs to reduce breast cancer recurrence and mortality. Breast Cancer Res 20(1):144","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2156_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2012.08.031","volume":"329","author":"A Gopalan","year":"2013","unstructured":"Gopalan A et al (2013) Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK\/CHOP\/DR5 signaling pathway. Cancer Lett 329(1):9\u201316","journal-title":"Cancer Lett"},{"issue":"12","key":"2156_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nrc1751","volume":"5","author":"MF Demierre","year":"2005","unstructured":"Demierre MF et al (2005) Statins and cancer prevention. Nat Rev Cancer 5(12):930\u2013942","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2156_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/joim.12806","volume":"284","author":"S Borgquist","year":"2018","unstructured":"Borgquist S et al (2018) Statins: a role in breast cancer therapy? J Intern Med 284(4):346\u2013357","journal-title":"J Intern Med"},{"issue":"10","key":"2156_CR11","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/s41416-018-0252-1","volume":"119","author":"R Langballe","year":"2018","unstructured":"Langballe R et al (2018) Statin use and risk of contralateral breast cancer: a nationwide cohort study. Br J Cancer 119(10):1297\u20131305","journal-title":"Br J Cancer"},{"issue":"1","key":"2156_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12885-018-5263-z","volume":"19","author":"S Borgquist","year":"2019","unstructured":"Borgquist S et al (2019) Statin use and breast cancer survival - a Swedish nationwide study. BMC Cancer 19(1):54","journal-title":"BMC Cancer"},{"issue":"6","key":"2156_CR13","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/ijc.30185","volume":"139","author":"S Manthravadi","year":"2016","unstructured":"Manthravadi S, Shrestha A, Madhusudhana S (2016) Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis. Int J Cancer 139(6):1281\u20131288","journal-title":"Int J Cancer"},{"issue":"1","key":"2156_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13058-023-01697-2","volume":"25","author":"LL L\u00f6fling","year":"2023","unstructured":"L\u00f6fling LL et al (2023) Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: A Norwegian population-based cohort study. Breast Cancer Res 25(1):101","journal-title":"Breast Cancer Res"},{"issue":"10","key":"2156_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.38737","volume":"8","author":"S Harborg","year":"2025","unstructured":"Harborg S et al (2025) Postdiagnosis statin use and breast cancer mortality. JAMA Netw Open 8(10):e2538737","journal-title":"JAMA Netw Open"},{"issue":"10","key":"2156_CR16","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1007\/s12094-025-03935-9","volume":"27","author":"FCA de Moraes","year":"2025","unstructured":"de Moraes FCA et al (2025) Statins and prognosis of female breast cancer: A meta-analysis. Clin Transl Oncol 27(10):3886\u20133901","journal-title":"Clin Transl Oncol"},{"issue":"8","key":"2156_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/ehjcvp\/pvad057","volume":"9","author":"V Jaiswal","year":"2023","unstructured":"Jaiswal V et al (2023) Post-diagnostic statin use and its association with cancer recurrence and mortality in breast cancer patients: A systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother 9(8):731\u2013740","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"2","key":"2156_CR18","first-page":"356","volume":"4","author":"T Hyder","year":"2021","unstructured":"Hyder T et al (2021) Statins and endocrine resistance in breast cancer. Cancer Drug Resist 4(2):356\u2013364","journal-title":"Cancer Drug Resist"},{"issue":"9","key":"2156_CR19","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1158\/1055-9965.EPI-13-0414","volume":"22","author":"JA McDougall","year":"2013","unstructured":"McDougall JA et al (2013) Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiol Biomarkers Prev 22(9):1529\u20131537","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2156_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S0895-4356(02)00614-5","volume":"56","author":"P Beck","year":"2003","unstructured":"Beck P et al (2003) Statin use and the risk of breast cancer. J Clin Epidemiol 56(3):280\u2013285","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"2156_CR21","first-page":"5143","volume":"29","author":"M Eaton","year":"2009","unstructured":"Eaton M et al (2009) Statins and breast cancer in postmenopausal women without hormone therapy. Anticancer Res 29(12):5143\u20135148","journal-title":"Anticancer Res"},{"issue":"1","key":"2156_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40119-015-0035-1","volume":"4","author":"HW Leung","year":"2015","unstructured":"Leung HW et al (2015) Long-Term Use of Antihypertensive Agents and Risk of Breast Cancer: A Population-Based Case-Control Study. Cardiol Ther 4(1):65\u201376","journal-title":"Cardiol Ther"},{"issue":"8","key":"2156_CR23","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1089\/154099903322447710","volume":"12","author":"JA Cauley","year":"2003","unstructured":"Cauley JA et al (2003) Lipid-lowering drug use and breast cancer in older women: a prospective study. J Womens Health (Larchmt) 12(8):749\u2013756","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"2156_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/cncr.23129","volume":"112","author":"G Pocobelli","year":"2008","unstructured":"Pocobelli G et al (2008) Statin use and risk of breast cancer. Cancer 112(1):27\u201333","journal-title":"Cancer"},{"issue":"9","key":"2156_CR25","first-page":"943","volume":"30","author":"SA Lucht","year":"2019","unstructured":"Lucht SA et al (2019) Circulating lipids, mammographic density, and risk of breast cancer in the Nurses\u2019 Health Study and Nurses\u2019 Health Study II. Cancer Causes Control 30(9):943\u2013953","journal-title":"Cancer Causes Control"},{"issue":"9","key":"2156_CR26","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41416-025-02974-x","volume":"132","author":"C Skriver","year":"2025","unstructured":"Skriver C et al (2025) Statin use and risk of breast cancer among women with benign breast disease: a Danish nationwide cohort study. Br J Cancer 132(9):828\u2013836","journal-title":"Br J Cancer"},{"issue":"6","key":"2156_CR27","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00404-017-4533-3","volume":"296","author":"MM Islam","year":"2017","unstructured":"Islam MM et al (2017) Exploring association between statin use and breast cancer risk: an updated meta-analysis. Arch Gynecol Obstet 296(6):1043\u20131053","journal-title":"Arch Gynecol Obstet"},{"issue":"34","key":"2156_CR28","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1200\/JCO.2005.02.7045","volume":"23","author":"S Bonovas","year":"2005","unstructured":"Bonovas S et al (2005) Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies. J Clin Oncol 23(34):8606\u20138612","journal-title":"J Clin Oncol"},{"issue":"1","key":"2156_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10549-012-2154-x","volume":"135","author":"K Undela","year":"2012","unstructured":"Undela K, Srikanth V, Bansal D (2012) Statin use and risk of breast cancer: a meta-analysis of observational studies. Breast Cancer Res Treat 135(1):261\u2013269","journal-title":"Breast Cancer Res Treat"},{"key":"2156_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111425","volume":"172","author":"W Xu","year":"2024","unstructured":"Xu W et al (2024) Long-term statin use and risk of cancers: a target trial emulation study. J Clin Epidemiol 172:111425","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2156_CR31","first-page":"378","volume":"67","author":"M Picon-Ruiz","year":"2017","unstructured":"Picon-Ruiz M et al (2017) Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin 67(5):378\u2013397","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2156_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1158\/1055-9965.EPI-21-0688","volume":"31","author":"H Charvat","year":"2022","unstructured":"Charvat H et al (2022) Excess body fatness during early to mid-adulthood and survival from colorectal and breast cancer: a pooled analysis of five international cohort studies. Cancer Epidemiol Biomarkers Prev 31(2):325\u2013333","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"2156_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1158\/1055-9965.EPI-15-0654","volume":"25","author":"S Borgquist","year":"2016","unstructured":"Borgquist S et al (2016) Statin use and breast cancer risk in the Nurses\u2019 Health Study. Cancer Epidemiol Biomarkers Prev 25(1):201\u2013206","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"2156_CR34","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/ije\/dyw357","volume":"46","author":"M Gabrielson","year":"2017","unstructured":"Gabrielson M et al (2017) Cohort profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA). Int J Epidemiol 46(6):1740\u20131741g","journal-title":"Int J Epidemiol"},{"key":"2156_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-022-06664-7","author":"M Klintman","year":"2022","unstructured":"Klintman M et al (2022) Postmenopausal overweight and breast cancer risk; results from the KARMA cohort. Breast Cancer Res Treat. https:\/\/doi.org\/10.1007\/s10549-022-06664-7","journal-title":"Breast Cancer Res Treat"},{"key":"2156_CR36","unstructured":"L\u00e4kemedelsregistret. 2021; Available from: https:\/\/www.socialstyrelsen.se\/statistik-och-data\/register\/alla-register\/lakemedelsregistret\/."},{"key":"2156_CR37","unstructured":"Cancerregistret. 2021; Available from: https:\/\/www.socialstyrelsen.se\/statistik-och-data\/register\/alla-register\/cancerregistret\/."},{"key":"2156_CR38","unstructured":"D\u00f6dsorsaksregistret. 2021; Available from: https:\/\/www.socialstyrelsen.se\/statistik-och-data\/register\/alla-register\/dodsorsaksregistret\/."},{"key":"2156_CR39","unstructured":"NKBC. 2021; Available from: https:\/\/cancercentrum.se\/samverkan\/cancerdiagnoser\/brost\/kvalitetsregister\/."},{"key":"2156_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fphar.2013.00119","volume":"4","author":"PM Cruz","year":"2013","unstructured":"Cruz PM et al (2013) The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics. Front Pharmacol 4:119","journal-title":"Front Pharmacol"},{"issue":"5","key":"2156_CR41","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2174\/138161209787315684","volume":"15","author":"Q Zhou","year":"2009","unstructured":"Zhou Q, Liao JK (2009) Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Curr Pharm Des 15(5):467\u2013478","journal-title":"Curr Pharm Des"},{"issue":"5","key":"2156_CR42","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1158\/1055-9965.EPI-07-0726","volume":"17","author":"AS Kumar","year":"2008","unstructured":"Kumar AS et al (2008) Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users. Cancer Epidemiol Biomarkers Prev 17(5):1028\u20131033","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2156_CR43","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.breast.2022.01.003","volume":"61","author":"M Inasu","year":"2022","unstructured":"Inasu M et al (2022) Statin use and patterns of breast cancer recurrence in the Malm\u00f6 Diet and Cancer Study. Breast Edinburgh Scot 61:123\u2013128","journal-title":"Breast Edinburgh Scot"},{"issue":"1","key":"2156_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/oxfordjournals.epirev.a036119","volume":"15","author":"KE Malone","year":"1993","unstructured":"Malone KE, Daling JR, Weiss NS (1993) Oral contraceptives in relation to breast cancer. Epidemiol Rev 15(1):80\u201397","journal-title":"Epidemiol Rev"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02156-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-026-02156-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02156-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:53:18Z","timestamp":1777449198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-026-02156-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2156"],"URL":"https:\/\/doi.org\/10.1007\/s10552-026-02156-x","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}},{"value":"All participants signed informed consent and the study was approved by the ethical committee of the Karolinska Institute (# 2017\/958). The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent."}}],"article-number":"72"}}